化学
蛋白酶
蛋白酵素
蛋白质降解
细胞生物学
降级(电信)
细胞毒性
核仁素
DNA
免疫疗法
癌症免疫疗法
蛋白质工程
生物物理学
免疫系统
生物化学
丝氨酸蛋白酶
蛋白水解酶
靶蛋白
细胞外
HEK 293细胞
泛素
酶
内吞循环
纳米技术
分子生物学
细胞培养
作者
Yue Liu,Huijuan Cheng,Yi-Shan Liu,Wen-Jia Shi,Di You,Pei‐Qiang Ma,Bang‐Ce Ye
摘要
Targeted protein degradation as a therapeutic modality leverages cellular proteolytic pathways to specifically eliminate disease-associated proteins. However, the dependence on endogenous pathways limited its further development in safety and universality. We fabricate a DNA origami-based protease device (DOPD) for extracellular direct degradation of tumor-associated proteins by regulating the activity of the protease. The DOPD features a six-helix bundle structure with a dual-functional architecture: an inner catalytic layer assembling proteases and trap strands and an outer shielding layer decorated with poly(lactic- co -glycolic acid) to limit the protease activity. By incorporating a pH-sensitive switch and a recognition module, this system enables direct protein degradation by inducing proximity between target proteins and proteases. We demonstrate that this system specifically degrades nucleolin and PD-L1 on tumor cells under acidic conditions, exerting direct cytotoxicity on tumor cells and alleviating immunosuppression in immune cells. As a proof of concept, DOPD-mediated tumor immunotherapy was validated in a xenograft mouse model, underscoring its potential as a programmable platform for precise protein degradation.
科研通智能强力驱动
Strongly Powered by AbleSci AI